1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 25
1.4 CURRENCY 26
1.5 LIMITATIONS 26
1.6 STAKEHOLDERS 26

2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 28
2.1.2.1 Key data from primary sources 29
2.2 MARKET SIZE ESTIMATION 30
2.2.1 BOTTOM-UP APPROACH 30
2.2.2 TOP-DOWN APPROACH 31
2.2.3 GROWTH FORECAST 31
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.4 ASSUMPTIONS FOR THE STUDY 33

3 EXECUTIVE SUMMARY 34

4 PREMIUM INSIGHTS 38
4.1 CELL ANALYSIS: MARKET OVERVIEW 38
4.2 ASIA PACIFIC: CELL ANALYSIS MARKET SHARE, BY END USER & COUNTRY (2018) 39
4.3 CELL ANALYSIS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION) 40
4.4 CELL ANALYSIS MARKET, BY PROCESS, 2019 VS. 2024 (USD MILLION) 41
4.5 CELL ANALYSIS MARKET, BY END USER (2019–2024) 42
4.6 GEOGRAPHICAL SNAPSHOT OF THE CELL ANALYSIS MARKET 43

5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 45
5.2.1.1 Funding for cell-based research 45
5.2.1.2 Rising incidence of chronic and infectious diseases 45
5.2.2 RESTRAINTS 46
5.2.2.1 High cost of cell analysis instruments 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Emerging economies 47
5.2.3.2 Applications of cell analysis in personalized medicine 48
5.2.4 CHALLENGES 48
5.2.4.1 Dearth of skilled professionals 48

6 CELL ANALYSIS MARKET, BY PRODUCT 49
6.1 INTRODUCTION 50
6.2 FLOW CYTOMETRY PRODUCTS 51
6.2.1 REAGENTS & CONSUMABLES 52
6.2.1.1 Flow cytometry reagents & consumables to dominate the flow cytometry products market 52
6.2.2 INSTRUMENTS 52
6.2.2.1 Development of technologically advanced cell analyzers to drive the flow cytometry instruments market 52
6.2.3 ACCESSORIES 53
6.2.3.1 Flow cytometry accessories enable end users to customize flow cytometry instruments 53
6.2.4 SOFTWARE 54
6.2.4.1 Technological developments and the increasing availability of a wide range of data analysis software to drive the market for flow cytometry software 54
6.3 QPCR PRODUCTS 54
6.3.1 REAGENTS & CONSUMABLES 55
6.3.1.1 qPCR reagents & consumables to dominate the qPCR products market during the forecast period 55
6.3.2 INSTRUMENTS 56
6.3.2.1 The use of qPCR instruments is being driven by continuous technological advancements and the increasing availability of innovative qPCR instruments 56
6.4 CELL MICROARRAYS 57
6.4.1 CONSUMABLES 58
6.4.1.1 Growing applications of microarrays in various fields and the regular, repeated, & bulk purchase of consumables to support market growth 58
6.4.2 INSTRUMENTS 58
6.4.2.1 Cell microarray instruments are widely used in gene expression, functional biology, and drug discovery research 58
6.5 MICROSCOPES 59
6.5.1 ELECTRON MICROSCOPES 60
6.5.1.1 Electron microscopes segment to dominate the microscopes market 60
6.5.2 INVERTED MICROSCOPES 61
6.5.2.1 Inverted microscopes facilitate the imaging of live cells or microorganisms in natural conditions 61
6.5.3 STEREO MICROSCOPES 62
6.5.3.1 Stereo microscopes are low-magnification microscopes often used for observing large biological samples 62
6.5.4 FLUORESCENCE & CONFOCAL MICROSCOPES 62
6.5.4.1 Fluorescence microscopes are essential instruments in live-cell image analysis 62
6.5.5 PHASE-CONTRAST MICROSCOPES 63
6.5.5.1 Phase-contrast microscopy is an illumination technology that enhances the imaging of transparent and colorless objects without the staining of slides 63
6.5.6 NEAR-FIELD SCANNING OPTICAL MICROSCOPES 64
6.5.6.1 NSOMs have wide applications in the life sciences sector 64
6.5.7 OTHER MICROSCOPES 65
6.6 SPECTROPHOTOMETERS 65
6.6.1 SINGLE-MODE READERS 66
6.6.1.1 Single-mode readers to dominate the spectrophotometers market 66
6.6.2 MULTI-MODE READERS 67
6.6.2.1 Multi-mode spectrophotometers offer high-throughput capabilities in the phenotypic screening of cells 67
6.7 CELL COUNTERS 68
6.7.1 AUTOMATED CELL COUNTERS 69
6.7.1.1 Automated cell counters give reliable and quick results as compared to manual counting methods 69
6.7.2 HEMOCYTOMETERS & MANUAL CELL COUNTERS 70
6.7.2.1 Many research laboratories and academic institutions use manual cell counters due to their low cost 70
6.8 HIGH-CONTENT SCREENING SYSTEMS 71
6.8.1 INCREASING STUDIES ON CELL BEHAVIOR TO DRIVE THE GROWTH OF THIS MARKET 71
6.9 OTHER PRODUCTS 72

7 CELL ANALYSIS MARKET, BY PROCESS 74
7.1 INTRODUCTION 75
7.2 CELL IDENTIFICATION 76
7.2.1 CELL IDENTIFICATION DOMINATES THE MARKET, BY PROCESS 76
7.3 CELL VIABILITY 76
7.3.1 MEASUREMENT OF CELL VIABILITY PLAYS A FUNDAMENTAL ROLE IN ALL FORMS OF CELL CULTURE STUDIES 76
7.4 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION 77
7.4.1 STUDY OF CELL SIGNALING IS PRIMARILY CONDUCTED IN TOXICITY TESTS 77
7.5 CELL PROLIFERATION 78
7.5.1 CELL PROLIFERATION ANALYSIS IS USED TO MEASURE POPULATIONS FROM CELL DIVISION 78
?
7.6 CELL COUNTING & QUALITY CONTROL 78
7.6.1 APAC IS EXPECTED TO SHOW THE HIGHEST GROWTH IN THE CELL COUNTING & QUALITY CONTROL MARKET 78
7.7 CELL INTERACTION 79
7.7.1 CELL INTERACTION IS STUDIED IN CARCINOGENESIS AND ORGAN DYSFUNCTION 79
7.8 CELL STRUCTURE STUDY 80
7.8.1 CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY WILL SHOW HIGHEST GROWTH IN THE ASIA PACIFIC 80
7.9 TARGET IDENTIFICATION & VALIDATION 80
7.9.1 TARGET IDENTIFICATION IS A KEY PART OF DRUG DISCOVERY 80
7.10 SINGLE-CELL ANALYSIS 81
7.10.1 SINGLE-CELL ANALYSIS HAS WIDE APPLICATIONS IN CANCER RESEARCH, IMMUNOLOGY, AND STEM CELL RESEARCH 81

8 CELL ANALYSIS MARKET, BY END USER 82
8.1 INTRODUCTION 83
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CONTRACT RESEARCH ORGANIZATIONS (CROS) 83
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS ARE THE FASTEST-GROWING END USERS OF THE CELL ANALYSIS MARKET 83
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES 84
8.3.1 DEVELOPMENT OF COMPLEX & HIGHLY SPECIALIZED TESTS AND ASSAYS TO SUPPORT MARKET GROWTH 84
8.4 RESEARCH INSTITUTES 85
8.4.1 GROWING PREVALENCE OF CANCER TO DRIVE THE MARKET FOR THIS END-USER SEGMENT 85
8.5 CELL CULTURE COLLECTION REPOSITORIES 86
8.5.1 INCREASING AWARENESS OF PRESERVING CELLS TO DRIVE MARKET GROWTH 86
8.6 OTHER END USERS 87

9 CELL ANALYSIS MARKET, BY REGION 89
9.1 INTRODUCTION 90
9.2 NORTH AMERICA 91
9.2.1 US 96
9.2.1.1 The US dominates the North American cell analysis market 96
9.2.2 CANADA 101
9.2.2.1 Availability of public and private funding to drive the cell analysis market in Canada 101
9.3 EUROPE 106
9.3.1 GERMANY 112
9.3.1.1 Germany is the fastest-growing market for cell analysis in Europe 112
?
9.3.2 UK 117
9.3.2.1 Initiatives to strengthen the academic research infrastructure in the country to contribute to market growth 117
9.3.3 FRANCE 121
9.3.3.1 Presence of a large biotechnology industry in the country to support market growth 121
9.3.4 ITALY 125
9.3.4.1 Increasing research activities and conferences to drive the market for cell analysis in the country 125
9.3.5 SPAIN 129
9.3.5.1 Growth of the biotechnology sector expected to support market growth in Spain 129
9.3.6 REST OF EUROPE 134
9.4 ASIA PACIFIC 139
9.4.1 JAPAN 144
9.4.1.1 Japan to dominate the Asia Pacific market for cell analysis 144
9.4.2 CHINA 149
9.4.2.1 Developments in the biotechnology sector to support market growth in China 149
9.4.3 INDIA 153
9.4.3.1 Implementation of favorable government initiatives for the development of the biotechnology sector to drive market growth in India 153
9.4.4 ROAPAC 158
9.5 LATIN AMERICA 162
9.5.1 MAJOR PLAYERS ARE FOCUSING ON ESTABLISHING THEIR MANUFACTURING FACILITIES IN LATIN AMERICA TO LEVERAGE THE LOW LABOR COST?A KEY GROWTH DRIVER 162
9.6 MIDDLE EAST & AFRICA 167
9.6.1 SHORTAGE OF TRAINED PROFESSIONALS TO RESTRAIN THE GROWTH OF THE CELL ANALYSIS MARKET IN SEVERAL COUNTRIES IN THE MIDDLE EAST & AFRICA 167
10 COMPETITIVE LANDSCAPE 171
10.1 OVERVIEW 171
10.2 MARKET SHARE ANALYSIS, 2018 172
10.3 COMPETITIVE SCENARIO 174
10.3.1 PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS (2017–2019) 174
10.3.2 PRODUCT LAUNCHES (2017–2019) 175
10.3.3 EXPANSIONS (2017–2019) 176
10.3.4 ACQUISITIONS (2017–2019) 176
?
10.4 COMPETITIVE LEADERSHIP MAPPING 177
10.4.1 VENDOR INCLUSION CRITERIA 177
10.4.2 VISIONARY LEADERS 177
10.4.3 INNOVATORS 177
10.4.4 DYNAMIC DIFFERENTIATORS 177
10.4.5 EMERGING COMPANIES 177

11 COMPANY PROFILES 179
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 DANAHER 179
11.2 THERMO FISHER SCIENTIFIC 183
11.3 BECTON, DICKINSON AND COMPANY 187
11.4 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 190
11.5 MERCK KGAA 193
11.6 AGILENT TECHNOLOGIES 196
11.7 OLYMPUS CORPORATION 199
11.8 PROMEGA CORPORATION 201
11.9 PERKINELMER 203
11.10 TECAN TRADING AG 206
11.11 MILTENYI BIOTEC 208
11.12 CARL ZEISS 210
11.13 BIO-RAD LABORATORIES 212
11.14 SYSMEX CORPORATION 214
11.15 BIOSTATUS LIMITED 216
11.16 NANOCELLECT BIOMEDICAL 217
11.17 CELL BIOLABS, INC 219
11.18 CREATIVE BIOARRAY 220
11.19 MEIJI TECHNO 221
11.20 CYTEK BIOSCIENCES 222
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 223
12.1 DISCUSSION GUIDE 223
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 227
12.3 AVAILABLE CUSTOMIZATIONS 229
12.4 RELATED REPORTS 229
12.5 AUTHOR DETAILS 230